3
Nov
2025
China Learned from Us — and We Can Learn from Them
Over the last decade, China-based biotech companies learned from the best —us. They studied how the US biotech ecosystem was built: a fusion of basic science, venture capital, and entrepreneurial risk-taking. They learned how our scientists turned NIH-funded discoveries into startups, how our venture model backed innovation years before potential profit, and how collaboration between academia, biotech, and pharma fueled... Read More
3
Nov
2025
Manifold Bio Pockets $55M from Roche for Blood-Brain Barrier Shuttles
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.